BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11071651)

  • 1. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.
    Wang H; Zheng X; Behm FG; Ratnam M
    Blood; 2000 Nov; 96(10):3529-36. PubMed ID: 11071651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites.
    Hao H; Qi H; Ratnam M
    Blood; 2003 Jun; 101(11):4551-60. PubMed ID: 12543860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H; Ratnam M
    Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.
    Xu Y; Wang T; Tang R; Tang S
    Tumour Biol; 2010 Dec; 31(6):589-95. PubMed ID: 20632143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
    Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
    Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines.
    Shimizu T; Takeda K
    Cancer Res; 2000 Aug; 60(16):4544-9. PubMed ID: 10969805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
    Pan XQ; Zheng X; Shi G; Wang H; Ratnam M; Lee RJ
    Blood; 2002 Jul; 100(2):594-602. PubMed ID: 12091353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
    Glasow A; Prodromou N; Xu K; von Lindern M; Zelent A
    Blood; 2005 Jan; 105(1):341-9. PubMed ID: 15339853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.
    Parrella E; Gianni' M; Cecconi V; Nigro E; Barzago MM; Rambaldi A; Rochette-Egly C; Terao M; Garattini E
    J Biol Chem; 2004 Oct; 279(40):42026-40. PubMed ID: 15292163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
    Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
    Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells.
    Koo JS; Jetten AM; Belloni P; Yoon JH; Kim YD; Nettesheim P
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):351-7. PubMed ID: 10024510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
    Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
    Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
    Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.